268 related articles for article (PubMed ID: 16622116)
1. Intraperitoneal therapy for advanced ovarian cancer: will it become standard care?
Bankhead C
J Natl Cancer Inst; 2006 Apr; 98(8):510-2. PubMed ID: 16622116
[No Abstract] [Full Text] [Related]
2. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC
Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166
[No Abstract] [Full Text] [Related]
3. Intraperitoneal therapy for ovarian cancer: why has it not become standard?
Rowan K
J Natl Cancer Inst; 2009 Jun; 101(11):775-7. PubMed ID: 19470952
[No Abstract] [Full Text] [Related]
4. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal therapy of ovarian cancer.
Markman M
Semin Oncol; 1998 Jun; 25(3):356-60. PubMed ID: 9633848
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for ovarian cancer.
Cvitkovic E; Misset JL
N Engl J Med; 1996 May; 334(19):1269; author reply 1270. PubMed ID: 8606730
[No Abstract] [Full Text] [Related]
7. Is it time for some new approaches for treating advanced ovarian cancer?
McGuire WP
J Natl Cancer Inst; 2006 Aug; 98(15):1024-6. PubMed ID: 16882933
[No Abstract] [Full Text] [Related]
8. Intraperitoneal chemotherapy for ovarian cancer.
Hamilton CA; Berek JS
Curr Opin Oncol; 2006 Sep; 18(5):507-15. PubMed ID: 16894301
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
Bristow RE; Santillan A; Salani R; Diaz-Montes TP; Giuntoli RL; Meisner BC; Armstrong DK; Frick KD
Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of epithelial ovarian cancer.
Bhoola S; Hoskins WJ
Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of ovarian cancer].
Ochiai K
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
[TBL] [Abstract][Full Text] [Related]
12. Surgical response of advanced-stage borderline ovarian tumors to paclitaxel and cisplatin chemotherapy.
Eltabbakh GH; Srivastava A; Garafano LL
Gynecol Oncol; 2000 May; 77(2):343-4. PubMed ID: 10785499
[No Abstract] [Full Text] [Related]
13. [Advanced cancer of the ovary. The paclitaxel-cisplatin combination as the first-line standard of treatment].
Pecorelli S
Recenti Prog Med; 1999 Jun; 90(6):338-41. PubMed ID: 10399475
[No Abstract] [Full Text] [Related]
14. The impact of cisplat based chemotherapy on advanced ovarian cancer.
Prasad GR; Dalal AV; Tongaonkar HB; Chatterjee S; Kamat MR
J Postgrad Med; 1995; 41(4):95-8. PubMed ID: 10707728
[TBL] [Abstract][Full Text] [Related]
15. The role of intraperitoneal chemotherapy in ovarian cancer.
Markman M
Clin Adv Hematol Oncol; 2006 Nov; 4(11):809-10. PubMed ID: 17143249
[No Abstract] [Full Text] [Related]
16. Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.
Fung-Kee-Fung M; Provencher D; Rosen B; Hoskins P; Rambout L; Oliver T; Gotlieb W; Covens A;
Gynecol Oncol; 2007 Jun; 105(3):747-56. PubMed ID: 17368522
[TBL] [Abstract][Full Text] [Related]
17. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
Sugiyama T; Yoshizaki A; Hatayama S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1011-6. PubMed ID: 17637537
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy improves survival after resection of stage 1 ovarian cancer.
Kitchener HC
Cancer Treat Rev; 2005 Jun; 31(4):323-7. PubMed ID: 15905036
[No Abstract] [Full Text] [Related]
19. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for ovarian cancer.
Parmar MK; Sandercock J
N Engl J Med; 1996 May; 334(19):1268-9; author reply 1270. PubMed ID: 8606729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
